Targeted MET Inhibition in Castration-Resistant Prostate Cancer: A Randomized Phase II Study and Biomarker Analysis with Rilotumumab plus Mitoxantrone and Prednisone von RYAN, Charles J, ROSENTHAL, Mark, MIN ZHU, RUI TANG, OLINER, KellyS, YIZHOUJIANG, LOH, Elwyn, DUBEY, Sarita, GERRITSEN, Winald R, NG, Siobhan, ALUMKAL, Joshi, PICUS, Joel, GRAVIS, Gwenaëlle, FIZAZI, Karim, FORGET, Frédéric, MACHIELS, Jean-Pascal, SRINIVAS, Sandy

Volltext